Skip to main content
FinSpry Logo
FinSpry
RMD logo
RMD
(NYSE)
ResMed Inc.
$191.89-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ResMed (RMD) Stock Price & Financial Analysis

ResMed Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$190.21 - $192.55
52-Week High$293.81
52-Week Low$180.27
Open$191.55
Volume1.01M
Average Volume (3M)1.49M
Market Cap27.96B
Shares Outstanding145.72M
P/E Ratio (TTM)18.40
Forward P/E16.01
Price to Sales (P/S)5.05
Price to Book (P/B)4.31
EV/EBITDA12.33
Revenue (TTM)5.54B
Net Income (TTM)1.52B
Free Cash Flow (TTM)1.75B
EPS (TTM)$10.36
Profit Margin27.44%
Operating Margin34.57%
Return on Equity (ROE)23.41%
Debt to Equity0.10
50-Day MA$198.85
200-Day MA$234.16
52-Week Change-29.81%
Annual Dividend$2.40
Dividend Yield1.25%
Payout Ratio23.17%
Last Dividend Ex-DateMay 14, 2026

Frequently Asked Questions About ResMed

What is the current stock price for RMD?

As of the latest trading session, RMD stock trades at $191.89. The 52-week range is $180.27–$293.81, with a day range of $190.21–$192.55.

What is the P/E ratio for RMD?

ResMed's trailing P/E ratio is 18.4, meaning investors pay $18.4 for every $1 of annual earnings. The forward P/E is 16.0, reflecting analyst expectations for future earnings. ResMed operates in the Healthcare sector.

Does RMD pay dividends?

Yes, ResMed pays a 1.25% annual dividend yield ($2.40 per share). The payout ratio is 23.2%. The last ex-dividend date was 2026-05-14.

What do analysts recommend for RMD?

Based on 18 analysts, the consensus for RMD is Buy.

What is the market cap of RMD?

ResMed's market capitalization is $27.96B, classifying it as a large-cap company. ResMed operates in the Healthcare sector within the Medical Instruments & Supplies industry.